[1]
|
Computational structural correlation and bioavailability studies of Dronedarone impurity
PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ADVANCES IN MATERIAL SCIENCE AND CHEMISTRY (ICAMSC – 2023),
2024
DOI:10.1063/5.0222500
|
|
|
[2]
|
Development of an UPLC-QTOF-MS Method for the Simultaneous Estimation of Dronedarone and its Unlisted Pharmacopoeial Impurities
Journal of Analytical Chemistry,
2023
DOI:10.1134/S1061934823070122
|
|
|
[3]
|
Development and validation of two spectrophotometric methods for the estimation of Dronedarone impurity molecule: (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
Materials Today: Proceedings,
2021
DOI:10.1016/j.matpr.2020.11.913
|
|
|
[4]
|
Simultaneous and Trace Level Determination of Six Potential Impurities by
UPLC-ESI-MS/MS in Antiarrhythmic Drug: Dronedarone Hydrochloride
Asian Journal of Chemistry,
2020
DOI:10.14233/ajchem.2020.22588
|
|
|
[5]
|
Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products
Journal of Pharmaceutical and Biomedical Analysis,
2019
DOI:10.1016/j.jpba.2019.112985
|
|
|
[6]
|
Establishment of a stability indicating HPLC method for dronedarone hydrochloride in tablets and in cyclodextrin inclusion complexes: application to degradation kinetic studies
Chemical Papers,
2018
DOI:10.1007/s11696-018-0643-z
|
|
|
[7]
|
Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC–MS/TOF and MS n studies
Journal of Pharmaceutical and Biomedical Analysis,
2016
DOI:10.1016/j.jpba.2015.10.028
|
|
|